Septerna (SEPN) Earnings Date & Reports

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SEPN is expected to report earnings to rise 16.07% to -64 cents per share on November 19

Q3'25

Est.

$-0.65

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.05

The last earnings report on August 11 showed earnings per share of -56 cents, beating the estimate of -62 cents. With 202.30K shares outstanding, the current market capitalization sits at 643.36M.

View a ticker or compare two or three

Compare

SEPN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SEPN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SEPN showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details